Low to moderate dose
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 05 2024
30 05 2024
Historique:
received:
12
02
2024
accepted:
24
05
2024
medline:
31
5
2024
pubmed:
31
5
2024
entrez:
30
5
2024
Statut:
epublish
Résumé
The effects of low doses of ionizing radiation on atherosclerosis remain uncertain, particularly as regards the generation of pro- or anti-inflammatory responses, and the time scale at which such effects can occur following irradiation. To explore these phenomena, we exposed atheroprone ApoE
Identifiants
pubmed: 38816571
doi: 10.1038/s41598-024-63084-x
pii: 10.1038/s41598-024-63084-x
doi:
Substances chimiques
Cesium Radioisotopes
0
Apolipoproteins E
0
Antigens, Differentiation, Myelomonocytic
0
Antigens, CD
0
Cesium-137
4T2E65IAR7
CD68 protein, mouse
0
CD68 Molecule
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12450Informations de copyright
© 2024. The Author(s).
Références
Gisterå, A. & Hansson, G. K. The immunology of atherosclerosis. Nat. Rev. Nephrol. 13, 368–380. https://doi.org/10.1038/nrneph.2017.51 (2017).
doi: 10.1038/nrneph.2017.51
pubmed: 28392564
Little, M. P. Radiation and circulatory disease. Mutat. Res. Rev. 770(Pt B), 299–318. https://doi.org/10.1016/j.mrrev.2016.07.008 (2016).
doi: 10.1016/j.mrrev.2016.07.008
Hoving, S. et al. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(−/−) mice. Int. J. Radiat. Oncol. Biol. Phys. 71, 848–857. https://doi.org/10.1016/j.ijrobp (2008).
doi: 10.1016/j.ijrobp
pubmed: 18514779
Shimizu, Y. et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ. 340, b5349 (2010).
doi: 10.1136/bmj.b5349
pubmed: 20075151
pmcid: 2806940
McGale, P. et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother. Oncol. 100, 167–175 (2011).
doi: 10.1016/j.radonc.2011.06.016
pubmed: 21752480
Bashar, K. et al. Effects of neck radiation therapy on extra-cranial carotid arteries atherosclerosis disease prevalence: Systematic review and a meta-analysis. PLoS One. 9, e110389. https://doi.org/10.1371/journal.pone.0110389 (2014).
doi: 10.1371/journal.pone.0110389
pubmed: 25329500
pmcid: 4199672
Boivin, J. F., Hutchison, G. B., Lubin, J. H. & Mauch, P. Coronary artery disease mortality in patients treated for Hodgkin’s disease. Cancer. 69, 1241–1247. https://doi.org/10.1002/cncr.2820690528 (1992).
doi: 10.1002/cncr.2820690528
pubmed: 1739922
Vaiserman, A., Koliada, A., Zabuga, O. & Socol, Y. Health impacts of low-dose ionizing radiation: Current scientific debates and regulatory issues. Dose-Response. 16, 1559325818796331. https://doi.org/10.1177/1559325818796331 (2018).
doi: 10.1177/1559325818796331
pubmed: 30263019
pmcid: 6149023
Baselet, B., Rombouts, C., Benotmane, A. M., Baatout, S. & Aerts, A. Cardiovascular diseases related to ionizing radiation: The risk of low-dose exposure (Review). Int. J. Mol. Med. 38, 1623–1641. https://doi.org/10.3892/ijmm.2016.2777 (2016).
doi: 10.3892/ijmm.2016.2777
pubmed: 27748824
pmcid: 5117755
Mitchel, R. E. et al. Low-dose radiation exposure and atherosclerosis in ApoE−/− mice. Radiat. Res. 175, 665–676. https://doi.org/10.1667/RR2176.1 (2011).
doi: 10.1667/RR2176.1
pubmed: 21375359
pmcid: 3998759
Mancuso, M. et al. Acceleration of atherogenesis in ApoE−/− mice exposed to acute or low-dose-rate ionizing radiation. Oncotarget. 6, 31263–31271. https://doi.org/10.18632/oncotarget.5075 (2015).
doi: 10.18632/oncotarget.5075
pubmed: 26359350
pmcid: 4741603
Le Gallic, C. et al. Chronic internal exposure to low dose
doi: 10.1371/journal.pone.0128539
pubmed: 26046630
pmcid: 4457796
Ebrahimian, T. G. et al. Chronic exposure to external low-dose gamma radiation induces an increase in anti-inflammatory and anti-oxidative parameters resulting in atherosclerotic plaque size reduction in ApoE−/− Mice. Radiat. Res. 189(2), 187–196. https://doi.org/10.1667/RR14823.1 (2018).
doi: 10.1667/RR14823.1
pubmed: 29227739
Juniku, N., Micke, O., Seegenschmiedt, M. H. & Muecke, R. Radiotherapy for painful benign skeletal disorders: Results of a retrospective clinical quality assessment. Strahlenther. Onkol. 195, 1068–1073. https://doi.org/10.1007/s00066-019-01514-w (2019).
doi: 10.1007/s00066-019-01514-w
pubmed: 31456003
pmcid: 6868042
Kamiya, K. et al. Long-term effects of radiation exposure on health. Lancet. 386, 469–478. https://doi.org/10.1016/S0140-6736(15)61167-9 (2015).
doi: 10.1016/S0140-6736(15)61167-9
pubmed: 26251392
Ziegler-Heitbrock, L. et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 116, e74-80. https://doi.org/10.1182/blood-2010-02-258558 (2010).
doi: 10.1182/blood-2010-02-258558
pubmed: 20628149
Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 38, 79–91. https://doi.org/10.1016/j.immuni (2013).
doi: 10.1016/j.immuni
pubmed: 23273845
Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19, 71–82. https://doi.org/10.1016/s1074-7613(03)00174-2 (2003).
doi: 10.1016/s1074-7613(03)00174-2
pubmed: 12871640
Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185–194 (2007).
doi: 10.1172/JCI28549
pubmed: 17200718
pmcid: 1716202
Swirski, F. K., Weissleder, R. & Pittet, M. J. Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1424–1432. https://doi.org/10.1161/ATVBAHA.108.180521 (2009).
doi: 10.1161/ATVBAHA.108.180521
pubmed: 19372462
pmcid: 2746262
Robbins, C. S. et al. Extramedullary hematopoiesis generates Ly-6Chigh monocytes that infiltrate atherosclerotic lesions. Circulation. 125, 364–374 (2012).
doi: 10.1161/CIRCULATIONAHA.111.061986
pubmed: 22144566
Auffray, C. et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 317(5838), 666–670. https://doi.org/10.1126/science.1142883 (2007).
doi: 10.1126/science.1142883
pubmed: 17673663
Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327(5966), 656–661. https://doi.org/10.1126/science.1178331 (2010).
doi: 10.1126/science.1178331
pubmed: 20133564
pmcid: 2887389
Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204(12), 3037–3047. https://doi.org/10.1084/jem.20070885 (2007).
doi: 10.1084/jem.20070885
pubmed: 18025128
pmcid: 2118517
Sica, A. & Mantovani, A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Invest. 122, 787–795. https://doi.org/10.1172/JCI59643 (2012).
doi: 10.1172/JCI59643
pubmed: 22378047
pmcid: 3287223
Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13. https://doi.org/10.12703/P6-13 (2014).
doi: 10.12703/P6-13
pubmed: 24669294
pmcid: 3944738
Murray, P. J. et al. Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity. 41, 14–20. https://doi.org/10.1016/j.immuni.2014.06.008 (2014).
doi: 10.1016/j.immuni.2014.06.008
pubmed: 25035950
pmcid: 4123412
Song, K.-H. et al. Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation. Int. J. Radiat. Biol. 91(10), 795–803 (2015).
doi: 10.3109/09553002.2015.1068461
pubmed: 26136089
Tabas, I. & Lichtman, A. H. Monocyte-macrophages and T cells in atherosclerosis. Immunity 47, 621–634. https://doi.org/10.1016/j.immuni.2017.09.008 (2017).
doi: 10.1016/j.immuni.2017.09.008
pubmed: 29045897
pmcid: 5747297
Joven, J. et al. The results in rodent models of atherosclerosis are not interchangeable: The influence of diet and strain. Atherosclerosis. 195(2), e85-92 (2007).
doi: 10.1016/j.atherosclerosis.2007.06.012
pubmed: 17651742
Garali, I. et al. A strategy for multimodal data integration: application to biomarkers identification in spinocerebellar ataxia. Brief Bioinform. 19(6), 1356–1369. https://doi.org/10.1093/bib/bbx060 (2018).
doi: 10.1093/bib/bbx060
pubmed: 29106465
Westerhuis, J. A., Kourti, T. & MacGregor, J. F. Analysis of multiblock and hierarchical PCA and PLS models. J. Chemom. 12, 301–321 (1998).
doi: 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S
Swirski, F. K., Weissleder, R. & Pittet, M. J. Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. Arterioscler Thromb. Vasc. Biol. 29, 1424–1432. https://doi.org/10.1161/ATVBAHA.108.180521 (2009).
doi: 10.1161/ATVBAHA.108.180521
pubmed: 19372462
pmcid: 2746262
Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723–737. https://doi.org/10.1038/nri3073 (2011).
doi: 10.1038/nri3073
pubmed: 21997792
pmcid: 3422549
Ferrante, C. J. & Leibovich, S. J. Regulation of macrophage polarization and wound healing. Adv. Wound Care (New Rochelle) 1, 10–16. https://doi.org/10.1089/wound.2011.0307 (2012).
doi: 10.1089/wound.2011.0307
pubmed: 24527272
Kiefer, R., Kieseier, B. C., Stoll, G. & Hartung, H. P. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog. Neurobiol. 64, 109–127. https://doi.org/10.1016/s0301-0082(00)00060-5 (2001).
doi: 10.1016/s0301-0082(00)00060-5
pubmed: 11240209
Veremeyko, T., Yung, A. W. Y., Anthony, D. C., Strekalova, T. & Ponomarev, E. D. Early growth response gene-2 is essential for M1 and M2 macrophage activation and plasticity by modulation of the transcription factor CEBPβ. Front. Immunol. 9, 2515. https://doi.org/10.3389/fimmu (2018).
doi: 10.3389/fimmu
pubmed: 30443252
pmcid: 6221966
Martinez, F. O., Helming, L. & Gordon, S. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451–483. https://doi.org/10.1146/annurev.immunol.021908.132532 (2009).
doi: 10.1146/annurev.immunol.021908.132532
pubmed: 19105661
Orecchioni, M., Ghosheh, Y., Pramod, A. B. & Ley, K. Macrophage polarization: Different gene signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively activated macrophages. Front. Immunol. 10, 1084. https://doi.org/10.3389/fimmu.2019.01084 (2019).
doi: 10.3389/fimmu.2019.01084
pubmed: 31178859
pmcid: 6543837
De Paoli, F. et al. Macrophage phenotypes and their modulation in atherosclerosis. Circ. J. 78(8), 1775–1781. https://doi.org/10.1253/circj.cj-14-0621 (2014).
doi: 10.1253/circj.cj-14-0621
pubmed: 24998279
Wunderlich, R. et al. Low and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti-inflammatory cytokine milieu, but do not impact upon viability and phagocytic function. Clin. Exp. Immunol. 179, 50–61. https://doi.org/10.1111/cei.12344 (2015).
doi: 10.1111/cei.12344
pubmed: 24730395
Halade, G. V. & Kain, V. Obesity and cardiometabolic defects in heart failure pathology. Compr. Physiol. 7, 1463–1477. https://doi.org/10.1002/cphy.c170011 (2017).
doi: 10.1002/cphy.c170011
pubmed: 28915332
pmcid: 5903473
Virmani, R., Burke, A. P., Kolodgie, F. D. & Farb, A. Vulnerable plaque: The pathology of unstable coronary lesions. J. Interv. Cardiol. 15, 439–446. https://doi.org/10.1111/j.1540-8183.2002.tb01087.x (2002).
doi: 10.1111/j.1540-8183.2002.tb01087.x
pubmed: 12476646
Falk, E. Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 47(C7–12), 2005. https://doi.org/10.1016/j.jacc (2005).
doi: 10.1016/j.jacc
O’Farrell, A. M., Liu, Y., Moore, K. W. & Mui, A. L. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and-independent pathways. EMBO J. 17, 1006–1018. https://doi.org/10.1093/emboj/17.4.1006 (1998).
doi: 10.1093/emboj/17.4.1006
pubmed: 9463379
pmcid: 1170450
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R. & Mallat, Z. Vascular smooth muscle cells in atherosclerosis. Nat. Rev. Cardiol. 16, 727–744. https://doi.org/10.1038/s41569-019-0227-9 (2019).
doi: 10.1038/s41569-019-0227-9
pubmed: 31243391